Prostate cancer Board decisions

The Veteran's prostate cancer residuals are currently rated at 40 percent, and the Board finds that a higher rating is not warranted based on the evidence of record.

The Veteran's claims for service connection for prostate cancer and a back disability are being remanded due to the need for additional medical examinations.

The Veteran's claims for service connection for parathyroid cancer and prostate cancer, both alleged to be due to exposure to ionizing radiation in service, are being remanded for further development including obtaining a new dose assessment based on the Veteran's location during atmospheric testing.

The Veteran's prostate cancer, status post radiation therapy, is rated at 60 percent disabling due to urinary frequency and incontinence requiring absorbent materials more than four times a day. His lumbar spine degenerative disc disease with lumbosacral strain is also rated at 20 percent.

The Veteran is granted TDIU for the period from July 1, 2010 to March 16, 2011 based on his prostate cancer. He is also granted TDIU for the period since March 17, 2011 due to PTSD and physical residuals of an in-service shooting. SMC is restored for the entire period from July 1, 2010.

The Board denied the Veteran's claims for service connection for a right ear condition, left knee condition, and prostate cancer. The denial is based on the lack of evidence showing a direct relationship to service.

The Board has determined that the Veteran's claim for an increased rating for residuals of prostate cancer is denied as his condition does not warrant a higher evaluation than the current 60 percent assigned since September 7, 2010.

The Board has remanded the case due to a request for a Travel Board hearing and procedural issues related to a simultaneously contested claim.

The appeal is being remanded for additional development, including obtaining medical records and providing further opinions regarding the Veteran's service connection claims and TDIU claim. The case will be returned to the Board once all necessary steps have been taken.

The Board has dismissed the appeals due to the Veteran's death.

The Veteran's prostate cancer with prostatectomy is rated at 20 percent from April 2009, and the appeal for a higher rating or extraschedular consideration has been denied.

The Board has determined that the Veteran's prostate disorder, to include prostate cancer, is related to his military service and has granted service connection.

The Veteran's prostate cancer and skin disability are not related to his service, including exposure to herbicides. The claim for service connection is denied.

The Board denied the Veteran's claim for an effective date prior to April 14, 2010, for the grant of service connection for the residuals of status post-prostate cancer and prostatectomy. The decision states that VA received a claim on April 14, 2010, which is considered the effective date as it was the earliest date of receipt.

The Veteran's appeal was dismissed due to his death, and the Board has no jurisdiction to adjudicate the merits of this claim.

The Board has remanded the Veteran's claims for increased ratings for bilateral hearing loss and prostate cancer due to insufficient evidence in the record, particularly regarding functional impairment and additional treatment records.

The Board has remanded the case for additional development to verify potential herbicide exposure in Thailand, as per M21-MR.IV.ii.2.c.10.q.

The Veteran's initial 100% rating for prostate cancer due to radical prostatectomy was reduced to a 10% rating effective May 1, 2006. The reduction was upheld as the evidence did not show disabling dysfunctions of the genitourinary system or significantly disabling urinary incontinence or frequency.

The Veteran was granted service connection for lung cancer, but denied for prostate, pancreatic, colon and lymph node cancers for purposes of accrued benefits.

The Veteran's claim for an increased rating for prostate cancer status post radical prostatectomy is denied as the evidence does not show recurrence of prostate cancer or any worsening symptoms. The Veteran was previously rated at 60 percent and no higher rating is warranted based on current manifestations.